Striatal dopaminergic function in restless legs syndrome -: 18F-dopa and 11C-raclopride PET studies

被引:314
作者
Turjanski, N
Lee, AJ
Brooks, DJ
机构
[1] Hammersmith Hosp, MRC, Cyclotron Unit, London W12 0HS, England
[2] Inst Neurol, London WC1N 3BG, England
关键词
D O I
10.1212/WNL.52.5.932
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To use PET to study striatal dopaminergic function in restless legs syndrome (RLS). Background: RLS is a common disorder experienced by as much as 5% of the population. It has been suggested that this condition is associated with a disturbance of dopaminergic transmission. Methods: The authors measured nigrostriatal terminal dopamine storage with F-18-dopa and striatal D-2 receptor binding with C-11-raclopride PET in 13 RLS patients, five of whom were receiving treatment with L-dopa at the time of scanning. RLS results were compared with those of age-matched control subjects. Results: Mean caudate and putamen F-18-dopa uptake were mildly reduced in the RLS patients compared with control subjects, and this reached significance (p = 0.04) in the putamen. Mean D-2 binding was reduced in the caudate (p = 0.01) and the putamen (p = 0.008) in RLS patients compared with control subjects. Six of the 13 RLS patients had caudate and putamen D-2 binding reduced below the control range. Three other RLS patients showed only reduced putamen D-2 binding. There were no significant differences in striatal F-18-dopa uptake or D-2 binding between L-dopa-naive and L-dopa-treated RLS patients. Conclusions: These PET findings support the hypothesis of central dopaminergic dysfunction in RLS.
引用
收藏
页码:932 / 937
页数:6
相关论文
共 38 条
  • [1] TREATMENT OF RESTLESS LEGS SYNDROME WITH LEVODOPA PLUS BENSERAZIDE
    AKPINAR, S
    [J]. ARCHIVES OF NEUROLOGY, 1982, 39 (11) : 739 - 739
  • [2] BANNON MJ, 1983, PHARMACOL REV, V35, P53
  • [3] Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
    Breier, A
    Su, TP
    Saunders, R
    Carson, RE
    Kolachana, BS
    de Bartolomeis, A
    Weinberger, DR
    Weisenfeld, N
    Malhotra, AK
    Eckelman, WC
    Pickar, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) : 2569 - 2574
  • [4] REM-SLEEP DEPRIVATION ALTERS DOPAMINE D-2 RECEPTOR-BINDING IN THE RAT FRONTAL-CORTEX
    BROCK, JW
    HAMDI, A
    ROSS, K
    PAYNE, S
    PRASAD, C
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 52 (01) : 43 - 48
  • [5] TREATMENT OF RESTLESS LEGS SYNDROME AND PERIODIC MOVEMENTS DURING SLEEP WITH L-DOPA - A DOUBLE-BLIND, CONTROLLED-STUDY
    BRODEUR, C
    MONTPLAISIR, J
    GODBOUT, R
    MARINIER, R
    [J]. NEUROLOGY, 1988, 38 (12) : 1845 - 1848
  • [6] THE RELATIONSHIP BETWEEN LOCOMOTOR DISABILITY, AUTONOMIC DYSFUNCTION, AND THE INTEGRITY OF THE STRIATAL DOPAMINERGIC SYSTEM IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY, PURE AUTONOMIC FAILURE, AND PARKINSONS-DISEASE, STUDIED WITH PET
    BROOKS, DJ
    SALMON, EP
    MATHIAS, CJ
    QUINN, N
    LEENDERS, KL
    BANNISTER, R
    MARSDEN, CD
    FRACKOWIAK, RSJ
    [J]. BRAIN, 1990, 113 : 1539 - 1552
  • [7] DIFFERING PATTERNS OF STRIATAL F-18 DOPA UPTAKE IN PARKINSONS-DISEASE, MULTIPLE SYSTEM ATROPHY, AND PROGRESSIVE SUPRANUCLEAR PALSY
    BROOKS, DJ
    IBANEZ, V
    SAWLE, GV
    QUINN, N
    LEES, AJ
    MATHIAS, CJ
    BANNISTER, R
    MARSDEN, CD
    FRACKOWIAK, RSJ
    [J]. ANNALS OF NEUROLOGY, 1990, 28 (04) : 547 - 555
  • [8] Brooks DJ., 1998, PARKINSONS DIS MOVEM, P991
  • [9] Cerebral generators involved in the pathogenesis of the restless legs syndrome
    Bucher, SF
    Seelos, KC
    Oertel, WH
    Reiser, M
    Trenkwalder, C
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (05) : 639 - 645
  • [10] Reflex studies and MRI in the restless legs syndrome
    Bucher, SF
    Trenkwalder, C
    Oertel, WH
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1996, 94 (02): : 145 - 150